|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embryo |
Human Reproduction Unit, Royal North Shore Hospital,3
Developmental Physiology Laboratory,4 Department of Physiology, University of Sydney, Sydney, New South Wales, 2065 Australia
Platelet-activating factor (PAF) is an autocrine trophic/survival factor for the preimplantation embryo. PAF induced an increase in intracellular calcium concentration ([Ca2+]i) in the 2-cell embryo that had an absolute requirement for external calcium. L-type calcium channel blockers (diltiazem, verapamil, and nimodipine) significantly inhibited PAF-induced Ca2+ transients, but inhibitors of P/Q type (
-agatoxin;
-conotoxin MVIIC), N-type (
-conotoxin GVIA), T-type (pimozide), and store-operated channels (SKF 96365 and econazole) did not block the transient. mRNA and protein for the
1-C subunit of L-type channels was expressed in the 2-cell embryo. The L-type calcium channel agonist (±) BAY K 8644 induced [Ca2+]i transients and, PAF and BAY K 8644 each caused mutual heterologous desensitization of each other's responses. Depolarization of the embryo (75 mM KCl) induced a [Ca2+]i transient that was inhibited by diltiazem and verapamil. Whole-cell patch-clamp measurements detected a voltage-gated channel (blocked by diltiazem, verapamil, and nifedipine) that was desensitized by prior responses of embryos to exogenous or embryo-derived PAF. Replacement of media Ca2+ with Mn2+ allowed Mn2+ influx to be observed directly; activation of a diltiazem-sensitive influx channel was an early response to PAF. The activation of a voltage-gated L-type calcium channel in the 2-cell embryo is required for normal signal transduction to an embryonic trophic factor.
2 Correspondence. FAX: 61 2 9926 6343; chriso{at}med.usyd.edu.au
This article has been cited by other articles:
![]() |
X.L. Jin, V. Chandrakanthan, H.D. Morgan, and C. O'Neill Preimplantation Embryo Development in the Mouse Requires the Latency of TRP53 Expression, Which Is Induced by a Ligand-Activated PI3 Kinase/AKT/MDM2-Mediated Signaling Pathway (Reprinted with Correction) Biol Reprod, July 1, 2009; 81(1): 233 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.L. Jin, V. Chandrakanthan, H.D. Morgan, and C. O'Neill Preimplantation Embryo Development in the Mouse Requires the Latency of TRP53 Expression, Which Is Induced by a Ligand-Activated PI3 Kinase/AKT/MDM2-Mediated Signaling Pathway Biol Reprod, February 1, 2009; 80(2): 286 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O'Neill Phosphatidylinositol 3-kinase signaling in mammalian preimplantation embryo development Reproduction, August 1, 2008; 136(2): 147 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O'Neill The potential roles for embryotrophic ligands in preimplantation embryo development Hum. Reprod. Update, May 1, 2008; 14(3): 275 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, V. Chandrakanthan, M. L Day, and C. O'Neill Direct Evidence for the Action of Phosphatidylinositol (3,4,5)-Trisphosphate-Mediated Signal Transduction in the 2-Cell Mouse Embryo Biol Reprod, November 1, 2007; 77(5): 813 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, V. Chandrakanthan, O. Chami, and C. O'Neill Culture of Zygotes Increases p53 Expression in B6 Mouse Embryos, which Reduces Embryo Viability Biol Reprod, March 1, 2007; 76(3): 362 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O'Neill The role of paf in embryo physiology Hum. Reprod. Update, May 1, 2005; 11(3): 215 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Lu, V. Chandrakanthan, A. Cahana, S. Ishii, and C. O'Neill Trophic signals acting via phosphatidylinositol-3 kinase are required for normal pre-implantation mouse embryo development J. Cell Sci., March 15, 2004; 117(8): 1567 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-G. Feng, M. Li, and L. G. Navar T-type calcium channels in the regulation of afferent and efferent arterioles in rats Am J Physiol Renal Physiol, February 1, 2004; 286(2): F331 - F337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |